&Partners’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.64M | Buy |
14,703
+858
| +6% | +$329K | 0.04% | 343 |
|
|
2025
Q1 | $4.74M | Buy |
13,845
+138
| +1% | +$47.2K | 0.05% | 308 |
|
|
2024
Q4 | $4.1M | Buy |
13,707
+3,204
| +31% | +$959K | 0.05% | 311 |
|
|
2024
Q3 | $4.27M | Sell |
10,503
-259
| -2% | -$105K | 0.08% | 227 |
|
|
2024
Q2 | $3.46M | Buy |
10,762
+168
| +2% | +$54K | 0.15% | 152 |
|
|
2024
Q1 | $3.53M | Buy |
10,594
+2,735
| +35% | +$912K | 0.49% | 40 |
|
|
2023
Q4 | $2.13M | Buy |
7,859
+33
| +0.4% | +$8.93K | 0.52% | 47 |
|
|
2023
Q3 | $1.93M | Buy |
7,826
+2,929
| +60% | +$720K | 0.9% | 22 |
|
|
2023
Q2 | $1.49M | Buy |
+4,897
| New | +$1.49M | 0.67% | 27 |
|
|
2022
Q2 | – | Sell |
-2,975
| Closed | -$746K | – | 203 |
|
|
2022
Q1 | $746K | Sell |
2,975
-250
| -8% | -$62.7K | 0.42% | 57 |
|
|
2021
Q4 | $829K | Sell |
3,225
-22
| -0.7% | -$5.66K | 0.5% | 47 |
|
|
2021
Q3 | $788K | Hold |
3,247
| – | – | 0.5% | 49 |
|
|
2021
Q2 | $671K | Sell |
3,247
-20
| -0.6% | -$4.13K | 0.43% | 59 |
|
|
2021
Q1 | $615K | Buy |
3,267
+22
| +0.7% | +$4.14K | 0.45% | 60 |
|
|
2020
Q4 | $534K | Buy |
3,245
+80
| +3% | +$13.2K | 0.45% | 58 |
|
|
2020
Q3 | $395K | Buy |
3,165
+125
| +4% | +$15.6K | 0.4% | 67 |
|
|
2020
Q2 | $295K | Buy |
+3,040
| New | +$295K | 0.36% | 73 |
|